CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 58 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $126,000 | -21.7% | 10,692 | -51.6% | 0.05% | +14.0% |
| Q4 2016 | $161,000 | -80.5% | 22,111 | -85.4% | 0.04% | -71.5% |
| Q2 2016 | $824,000 | +115.1% | 150,979 | +84.6% | 0.15% | +174.5% |
| Q1 2016 | $383,000 | -82.5% | 81,788 | -81.3% | 0.06% | -76.6% |
| Q4 2015 | $2,183,000 | +82.5% | 438,371 | +37.9% | 0.24% | +104.3% |
| Q3 2015 | $1,196,000 | -36.7% | 317,997 | +1.2% | 0.12% | -37.5% |
| Q2 2015 | $1,888,000 | +2486.3% | 314,095 | +2315.0% | 0.18% | +2528.6% |
| Q1 2015 | $73,000 | -45.5% | 13,006 | -73.9% | 0.01% | -41.7% |
| Q3 2014 | $134,000 | -68.5% | 49,868 | -67.3% | 0.01% | -64.7% |
| Q2 2014 | $426,000 | -80.6% | 152,271 | -69.7% | 0.03% | -76.6% |
| Q1 2014 | $2,193,000 | +263.7% | 502,989 | +167.7% | 0.14% | +417.9% |
| Q4 2013 | $603,000 | +161.0% | 187,923 | +29.2% | 0.03% | +154.5% |
| Q3 2013 | $231,000 | -56.2% | 145,395 | -52.3% | 0.01% | -50.0% |
| Q2 2013 | $527,000 | – | 304,667 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,340,193 | $227,229 | 10.94% |
| Novo Holdings A/S | 3,377,768 | $92,044,178 | 6.80% |
| Parallel Advisors, LLC | 3,723,483 | $101,446,294 | 3.38% |
| TANAKA CAPITAL MANAGEMENT INC | 37,569 | $1,024 | 2.92% |
| S&T BANK/PA | 334,252 | $9,107 | 1.76% |
| Birchview Capital, LP | 50,000 | $1,362,250 | 1.16% |
| Granite Investment Partners, LLC | 798,552 | $21,756,549 | 0.91% |
| FAS Wealth Partners, Inc. | 310,764 | $8,466,766 | 0.90% |
| Clearview Wealth Advisors LLC | 25,258 | $688,155 | 0.85% |
| Bridge City Capital, LLC | 43,485 | $1,184,749 | 0.60% |